Dihexa Research Hub — HGF Mimetic & Synaptogenesis Studies
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small-molecule hepatocyte growth factor (HGF) mimetic widely cited in synaptogenesis and cognitive-research models. This hub aggregates the published reference material.
What this hub covers
- HGF / c-Met receptor pathway agonism
- Spinogenesis and synaptic-density literature
- Cognitive and neuro-research models
- Oral and intranasal research formats
Dihexa research articles
All research →Dihexa Research Overview
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a potent hepatocyte growth factor (HGF) mimetic peptide derived from angiotensin IV — studied for its ability to restore synaptogenesis, increase dendritic spine density, and reverse cognitive deficits in neurodegenerative disease models at concentrations far below any other characterised cognitive-enhancing compound.
Read article →Related research hubs
Researchers studying Dihexa commonly cross-reference these compounds.
Dihexa research FAQ
- What is Dihexa?
- Dihexa is a small-molecule angiotensin-IV analogue developed as a hepatocyte growth factor (HGF) mimetic, widely cited in synaptogenesis and cognitive-research literature.
- What is the most-cited mechanism?
- Potentiation of HGF / c-Met receptor signalling, leading to dendritic-spine formation and synaptogenesis in published in-vitro and rodent models.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.